| Literature DB >> 33616693 |
Shu Wang1, Yuan Zhang2,3, Yuguang Guan1,4,5, Wei Ding6, Yao Meng7, Huiting Hu8, Zhenhua Liu9, Xianwei Zeng10, Minzhong Wang11.
Abstract
PURPOSE: To evaluate the prevalence of and risk factors associated with anxiety, depression, and insomnia symptoms during the return-to-work period of coronavirus disease 2019 in China.Entities:
Keywords: Anxiety; Coronavirus disease 2019; Cross-sectional; Depression; Insomnia
Mesh:
Year: 2021 PMID: 33616693 PMCID: PMC7898251 DOI: 10.1007/s00127-021-02046-4
Source DB: PubMed Journal: Soc Psychiatry Psychiatr Epidemiol ISSN: 0933-7954 Impact factor: 4.519
Fig. 1Sketch map showing the region division, sampling centers and epidemic area. Sampling region stratified by National Economic Population Division (NEPD; East, Center, West, Northwest); epidemic area stratified by daily number of new cases (DNC; Area I DNC ≥ 10, Area II 10 > DNC > 0, Area III DNC = 0)
Fig. 2Flow diagram showing the sampling process. NEPD: National Economic Population Division; DNC: daily number of new cases
Participants’ characteristics and experience (n = 36,795)
| Subject | % | |
|---|---|---|
| Area | ||
| I | 2,871 | 7.80 |
| II | 16,713 | 45.42 |
| III | 17,211 | 46.78 |
| Gender | ||
| Male | 18,732 | 50.91 |
| Female | 18,063 | 49.09 |
| Age (years) | ||
| ≤ 17 | 3,179 | 8.64 |
| 18–34 | 9,585 | 26.05 |
| 35–49 | 10,067 | 27.36 |
| 50–64 | 8,263 | 22.46 |
| ≥ 65 | 5,701 | 15.49 |
| Epidemic status | ||
| Cured patients | 2337 | 6.35 |
| Confirmed patients | 374 | 1.02 |
| Suspected infection | 201 | 0.55 |
| Close contacts | 529 | 1.44 |
| Frontline medical staff | 892 | 2.42 |
| Others | 32,462 | 88.22 |
| Outside activity/once | ||
| 1–7 days | 17,323 | 47.08 |
| 8–14 days | 12,307 | 33.45 |
| 15–29 days | 4031 | 10.96 |
| ≥ 30 days | 3134 | 8.52 |
| Resumption status | ||
| On-site work resumption | 15,063 | 40.94 |
| Off-site work resumption | 9960 | 27.07 |
| No work resumption | 4189 | 11.38 |
| Off-site study resumption | 6834 | 18.57 |
| No study resumption | 749 | 2.04 |
Refer to Supplementary Table S1 for detailed characteristics, and Supplementary Table S2 for detailed experience
Results of overall risk factors of anxiety depression and insomnia symptoms by multivariate analyses
| Scale | Variables | OR | 95% CI | |
|---|---|---|---|---|
| GAD-7 | Area I | 1.304 | 1.012–2.129 | 0.027* |
| Age 50–64 years | 2.431 | 1.823–3.280 | 0.004** | |
| Frontline medical staff | 2.150 | 1.346–2.646 | 0.017* | |
| Outside activity once in ≥ 30 days | 2.719 | 1.718–3.910 | 0.003** | |
| PHQ-9 | Age 50–64 years | 1.936 | 1.223–3.218 | 0.023* |
| Outside activity once in ≥ 30 days | 2.074 | 1.384–3.023 | 0.019* | |
| ISI | Area I | 1.242 | 1.038–2.257 | 0.035* |
| Age 50–64 years | 2.036 | 1.162–2.973 | 0.007** | |
| Outside activity once in ≥ 30 days | 2.225 | 1.238–4.143 | 0.003** |
The variables showing p < 0.05 in the univariate analysis were entered into the multiple logistic regression model in a backward fashion to adjust for confounding effects of variables included in the multiple logistic regression. The contrast was set as indicator determined by the group with lowest prevalence of anxiety, depression, or insomnia symptoms to explore the risk factors. The multicollinearity diagnostics showed variables that were included in the multivariate analysis did not have significant multicollinearity (variance inflation factor, VIF < 10)
GAD-7 the generalized anxiety disorder-7 scale, PHQ-9 the patient health questionnaire-9, ISI the insomnia severity index, SARS severe acute respiratory syndrome, outbreak in 2003, China
*p < 0.05 (multivariate logistic regression)
**p < 0.01 (multivariate logistic regression)
Risk factors of anxiety depression and insomnia symptoms (stratified by epidemic area, epidemic status, or resumption status) by multivariate analyses
| Subgroup | Scale | Variables | OR | 95% CI | |
|---|---|---|---|---|---|
| Stratified by epidemic area | |||||
| Area I | GAD-7 | Age 50–64 years | 1.837 | 1.324–2.539 | 0.021* |
| Frontline medical staff | 2.964 | 1.837–5.134 | 0.005** | ||
| PHQ-9 | Outside activity once in ≥ 30 days | 2.453 | 1.212–3.628 | 0.010* | |
| Only public psychological intervention | 2.031 | 1.108–2.825 | 0.019* | ||
| Area II | GAD-7 | Frontline medical staff | 2.054 | 1.139–3.195 | 0.017* |
| Off-site work resumption | 1.878 | 1.057–2.354 | 0.030* | ||
| PHQ-9 | Age 35–49 years | 1.641 | 1.155–2.177 | 0.037* | |
| Outside activity once in ≥ 30 days | 2.367 | 1.586–3.141 | 0.012* | ||
| Area III | GAD-7 | Male | 1.353 | 1.024–1.835 | 0.041* |
| Age 50–64 years | 2.251 | 1.328–3.356 | 0.008** | ||
| Stratified by epidemic status | |||||
| E4 | GAD-7 | Age ≥ 65 years | 2.280 | 1.165–3.648 | 0.007** |
| E6 | GAD-7 | Area I | 1.574 | 1.056–2.331 | 0.018* |
| Age 50–64 years | 2.699 | 1.209–3.415 | 0.009** | ||
| PHQ-9 | Age 50–64 years | 1.817 | 1.137–2.789 | 0.012* | |
| Outside activity once in ≥ 30 days | 2.128 | 1.257–3.401 | 0.006** | ||
| No psychological intervention | 1.916 | 1.046–3.471 | 0.019* | ||
| Stratified by resumption status | |||||
| R1 | GAD-7 | Medical staff | 2.667 | 1.513–3.690 | 0.018* |
| Enterprise management | 2.018 | 1.319–4.021 | 0.023* | ||
| ISI | Age 35–49 years | 1.830 | 1.227–3.129 | 0.029* | |
| Government staff | 1.931 | 1.332–3.235 | 0.027* | ||
| Enterprise management | 2.049 | 1.193–3.790 | 0.014* | ||
| R2 | ISI | Only public psychological intervention | 2.128 | 1.275–3.091 | 0.005** |
| Outside activity once in 15–29 days | 1.527 | 1.156–2.874 | 0.023* | ||
| R3 | GAD-7 | Enterprise management | 3.053 | 1.885–5.026 | 0.008** |
| Outside activity once in ≥ 30 days | 2.269 | 1.537–3.055 | 0.014* | ||
| ISI | Enterprise management | 3.099 | 1.870–5.023 | 0.006** | |
| Outside activity once in 15–29 days | 2.034 | 1.257–2.803 | 0.011* | ||
The variables showing p < 0.05 in the univariate analysis were entered into the multiple logistic regression model in a backward fashion to adjust for confounding effects of variables included in the multiple logistic regression. The contrast was set as indicator determined by the group with lowest prevalence of anxiety, depression, or insomnia symptoms to explore the risk factors. The multicollinearity diagnostics showed variables that were included in the multivariate analysis did not have significant multicollinearity (Variance inflation factor, VIF < 10)
GAD-7 the generalized anxiety disorder-7 scale, PHQ-9 the patient health questionnaire-9, ISI the insomnia severity index, SARS severe acute respiratory syndrome, outbreak in 2003, China, E4 close contacts (except frontline medical staff), E5 frontline medical staff, E6 others, R1 on-site work resumption, R2 off-site work resumption, R3 no work resumption, R5 off-site study resumption
*p < 0.05 (multivariate logistic regression)
**p < 0.01 (multivariate logistic regression)